Barbara Ensoli
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Editorial: HIV-1 Tat, an enhancer of virus infectivity and disease promoter: target for preventive and therapeutic interventions.
Journal: Frontiers in immunology
Published: May 14, 2026
Therapeutic HIV-1 Tat vaccination promotes durable immune reconstitution and reservoir reduction in ART-treated adults with clade C infection: a 12-year follow-up study.
Journal: Frontiers in immunology
Published: December 16, 2025
Clinical Efficacy of the HIV Protease Inhibitor Indinavir in Combination with Chemotherapy for Advanced Classic Kaposi Sarcoma Treatment: A Single-Arm, Phase II Trial in the Elderly.
Journal: Cancer research communications
Published: February 15, 2024
Role of HIV-1 Tat Protein Interactions with Host Receptors in HIV Infection and Pathogenesis.
Journal: International journal of molecular sciences
Published: December 30, 2023
Epidemiological and molecular characterization of HBV and HCV infections in HIV-1-infected inmate population in Italy: a 2017-2019 multicenter cross-sectional study.
Journal: Scientific reports
Published: March 14, 2023
HIV-1 therapeutic vaccines in clinical development to intensify or replace antiretroviral therapy: the promising results of the Tat vaccine.
Journal: Expert review of vaccines
Published: June 13, 2022
Kaposi's Sarcoma Lesion Progression in BKV-Tat Transgenic Mice Is Increased by Inflammatory Cytokines and Blocked by Treatment with Anti-Tat Antibodies.
Journal: International journal of molecular sciences
Published: December 22, 2021
Anti-Tat immunity defines CD4+ T-cell dynamics in people living with HIV on long-term cART.
Journal: EBioMedicine
Published: January 14, 2021
New insights into pathogenesis point to HIV-1 Tat as a key vaccine target.
Journal: Archives of virology
Published: January 14, 2021
HIV-1 Tat Protein Enters Dysfunctional Endothelial Cells via Integrins and Renders Them Permissive to Virus Replication.
Journal: International journal of molecular sciences
Published: November 19, 2020
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation.
Journal: Vaccines
Published: April 28, 2020
HIV Protease Inhibitors Block HPV16-Induced Murine Cervical Carcinoma and Promote Vessel Normalization in Association with MMP-9 Inhibition and TIMP-3 Induction.
Journal: Molecular cancer therapeutics
Published: January 22, 2020
Last Updated: 09/26/2026